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Phytosterols contain an unsaturated ring structure and therefore are susceptible to oxidation under certain conditions. Whilst the cytotoxicity of the analo-
gous cholesterol oxidation products (COP) has been well documented, the biological effects of phytosterol oxidation products (POP) have not yet been fully
ascertained. The objective of the present study was to examine the cytotoxicity of b-sitosterol oxides and their corresponding COP in a human monocytic
cell line (U937), a colonic adenocarcinoma cell line (CaCo-2) and a hepatoma liver cell line (HepG2). 7b-Hydroxysitosterol, 7-ketositosterol, sitosterol-
3b,5a,6b-triol and a sitosterol-5a,6a-epoxide–sitosterol-5b,6b-epoxide (6:1) mixture were found to be cytotoxic to all three cell lines employed; the
mode of cell death was by apoptosis in the U937 cell line and necrosis in the CaCo-2 and HepG2 cells. 7b-Hydroxysitosterol was the only b-sitosterol
oxide to cause depletion in glutathione, indicating that POP-induced apoptosis may not be dependent on the generation of an oxidative stress. A further
objective of this study was to assess the ability of the antioxidants a-tocopherol, g-tocopherol and b-carotene to modulate POP-induced cytotoxicity in
U937 cells. Whilst a/g-tocopherol protected against 7b-hydroxycholesterol-induced apoptosis, they did not confer protection against 7b-hydroxysitosterol-
or 7-ketositosterol-induced toxicity, indicating that perhaps COP provoke different apoptotic pathways than POP. b-Carotene did not protect against COP-
or POP-induced toxicity. In general, results indicate that POP have qualitatively similar toxic effects to COP. However, higher concentrations of POP are
required to elicit comparable levels of toxicity.
Phytosterol oxides: Cholesterol oxides: Cytotoxicity: Apoptosis
Plant sterols (phytosterols) are membrane constituents of all plants
with a structure analogous to that of cholesterol (zoosterols). Diet-
ary intakes are estimated to be between 160 and 400 mg/d among
different populations and are largely derived from vegetable oils,
nuts, seeds and grains (Ostlund, 2002). During the last decade
there has been an unprecedented escalation of interest in the poten-
tial health benefits of phytosterols, in particular as efficacious
cholesterol-lowering agents. Moreover, phytosterols may
possess anticarcinogenic, anti-atherosclerotic, anti-inflammatory
and anti-oxidative activities (De Jong et al. 2003; Berger et al.
2004). Consequently, esters of phytosterols are being incorporated
into a growing spectrum of functional foods such as margarine
and salad dressings in a number of countries (Moreau et al. 2002).
Dietary intakes are projected to increase accordingly. De Jong
et al. (2004) reported that if liberal phytosterol fortification is
allowed, the average daily intake might exceed 8·6 g.
Given their structural similarity to cholesterol, it is reasonable to
assume that phytosterols are also susceptible to oxidation.
The mechanisms of formation of cholesterol oxidation products
(COP) are well documented (Tai et al. 1999). Furthermore,
evidence exists that several COP may be linked to a series of
human diseases, including atherogenesis, cytotoxicity, mutagenesis
and carcinogenesis (Brown & Jessup, 1999). However, data on the
mechanism of phytosterol oxidation are very limited, as are data on
the level of phytosterol oxidation products (POP) present in food.
Some studies have noted modest amounts of POP in French
fries, potato chips and vegetable oils (Lee et al. 1985; Dutta,
1997; Dutta & Appelqvist, 1997), wheat flour (Nourooz-Zadeh
& Appelqvist, 1992), coffee (Turchetto et al. 1993) and commer-
cial margarine (Grandgirard, 2002). Limited evidence suggests
that some POP can pass the intestinal barrier, albeit at a low
level (Grandgirard et al. 1999; Tomoyori et al. 2004). Recently,
Grandgirard et al. (2004) identified appreciable quantities of oxi-
dised phytosterols in plasma samples of healthy individuals. Two
possibilities exist concerning the origin of these compounds in
plasma. First, they may stem from absorption of the small
amount of POP in food. However, second, their in vivo transform-
ation into phytosterol oxides cannot be excluded. Plat et al.
(2001) detected elevated levels of POP in serum of phytosterolae-
mic patients. In this latter study, phytosterol oxide concentrations
in the serum of healthy control samples were below the limit of
detection. In an earlier study, Aringer et al. (1976) observed a
27-hydroxylation of campesterol and sitosterol and a 29-hydroxy-
lation of sitosterol in rat liver mitochondria.
Data on biological effects of POP are scarce. Abortifacient
effects were described in mice (Pakrashi & Basak, 1976).
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Meyer & Spitellier (1997) described an increase in POP during
ageing of photoautotrophic cell cultures, as well as cytotoxicity
of these compounds in mealworms (Meyer et al. 1998). Adcox
et al. (2001) demonstrated that a mixture of POP caused cellular
damage in cultured macrophage-derived cells similar to that
caused by COP. More recently, Maguire et al. (2003) reported
that thermally oxidised derivatives of phytosterols demonstrate
similar patterns of toxicity towards a human monocytic cell line
(U937) as the COP 7b-hydroxycholesterol, but at higher concen-
trations. The authors describe the evaluation of epoxide prepared
by the oxidation of commercial b-sitosterol (approximately 60%
purity). In view of the projected increase in the consumption of
foods enriched with phytosterols, which are known to be liable
to oxidation, together with the undesirable health effects attribu-
ted to the related COP, additional information on the toxicological
significance of POP is warranted.
b-Sitosterol represents the most abundant phytosterol in
nature. Individual oxides of b-sitosterol were prepared for us
by colleagues in the Department of Chemistry, University Col-
lege Cork. The objective of the present study was to investigate
the cytotoxicity and apoptotic potential of individual b-sitosterol
oxides towards a human monocytic blood cell line (U937), a
colonic adenocarcinoma cell line (CaCo-2) and a human hepa-
toma cell line (HepG2). These cells were employed as U937
cells have previously been shown to undergo apoptosis when
treated with certain COP. CaCo-2 cells were used because the
gut is the initial site of exposure, absorption and metabolism
of dietary components. HepG2 cells retain many functions of
the normal liver cell and have been used in many studies eval-
uating the cytotoxic potential of compounds. For comparison,
the cytotoxic effects of the corresponding COP were also
assessed in each cell line. The effect of individual POP on cel-
lular glutathione levels was assessed in U937 cells as an index
of oxidative stress. A further objective was to assess the ability
of some antioxidants commonly found in human diets, i.e. a-
and g-tocopherol and b-carotene, to modulate POP-induced
cytotoxicity.
Materials and methods
Materials
All chemicals and cell culture reagents were obtained from Sigma
Chemical Co. (Poole, UK) unless otherwise stated. Tissue culture
plastics were supplied by Costar (Cambridge, UK). Cell lines
were obtained from the European Collection of Animal Cell Cul-
tures (Sailsbury, UK). Information on the purity of the cholesterol
oxides (purity .95 %) was obtained from Sigma.
Cell maintenance
Human monocytic U937 cells were grown in suspension in
RPMI 1640 medium supplemented with 2 mM-L-glutamine and
10 % (v/v) fetal calf serum (FCS). Human colonic adenocarci-
noma CaCo-2 cells were maintained in Dulbecco’s modified
Eagle’s medium supplemented with 10 % (v/v) FCS, 2 mM-L-glu-
tamine and 1 % non-essential amino-acids. HepG2, a human
hepatoma cell line, was grown in Williams E medium sup-
plemented with 2 mM-L-glutamine and 10 % (v/v) FCS. The
cells were grown at 378C and 5 % (v/v) CO2 in a humidified incu-
bator. Cells were screened for mycoplasm contamination by the
Hoechst staining method (Mowels, 1990) and were cultured in
the absence of antibiotics. Exponentially growing cells were
used throughout the experiments.
Production of b-sitosterol oxides
Individual POP are not commercially available and therefore
were synthesised, purified and characterised by the Analytical
and Biological Chemistry Research Facility (ABCRF) Depart-
ment of Chemistry, University College Cork (McCarthy et al.
2005). The target compounds were sitosterol-5a,6a-epoxide
(a-epoxysitosterol), synthesised as previously described by
Maguire et al. (2003) sitosterol-5b,6b-epoxide (b-epoxysitos-
terol), 7b-hydroxysitosterol, 7-ketositosterol and sitosterol-
3b,5a,6b-triol (triolsitosterol). The first objective was to
obtain b-sitosterol with the best possible purity, in order to pre-
pare unambiguous phytosterol oxides. Pure b-sitosterol (approxi-
mately 98·9 % purity) was synthesised from stigmasterol of
approximately 95 % purity from Sigma-Aldrich. The strategy
for the synthesis of b-sitosterol from stigmasterol involved the
protection of the double bond in the b-ring followed by hydro-
genation of the side-chain double bond. Ethanol was employed
as the solvent and Pd–C as the catalyst at 345 kPa pressure.
This was then followed by deprotection of the methyl ether to
give b-sitosterol of approximately 98·9 % purity as defined by
GC–MS and NMR spectroscopy. The second objective was to
synthesise the target oxidation products from this pure b-sitos-
terol. The procedures followed in this work were very similar
to those employed by Li & Wilson (1999) for the synthesis
of COP.
Cell treatment with b-sitosterol oxides
For experiments, U937 cells, CaCo-2 cells or HepG2 cells were
adjusted to a density of 2 £ 105 cells/ml supplemented with
reduced serum media, 2·5 % (v/v) FCS. Oxides of b-sitosterol
were added to the tissue culture medium at the concentration
of 30mM, 60mM or 120mM. For comparison, cells were also
incubated with 30mM of the corresponding cholesterol oxides,
namely, cholesterol-5a,6a-epoxide (a-epoxycholesterol), choles-
terol-5b,6b-epoxide (b-epoxycholesterol), 7b-hydroxycholes-
terol, 7-ketocholesterol and cholestane-3b,5a,6b-triol
(triolcholesterol). All compounds were dissolved in ethanol and
the final concentration in the cultures did not exceed 0·4 % (v/
v). Equivalent quantities of ethanol were added to control cells
and samples were incubated for 24 h at 378C and 5 % (v/v)
CO2. A concentration of 30mM COP was selected for this
study as it approximates the upper physiological concentration
found in human plasma. Emanuel et al. (1991) reported a con-
centration as high as 37mM in human plasma, following the
ingestion of a test meal of spray-dried powdered eggs. Since
this study is a comparative study of the cytotoxic and apoptotic
potential of POP with their corresponding COP, the phytosterol
oxides were used at concentrations as high as 120mM as this
is the concentration that showed similar toxic effects to the
COP. The concentration of POP used in our in vitro models is
higher than those encountered physiologically. Plat et al.
(2001) reported 7b-hydroxysitosterol concentrations about 2mM
and slightly higher concentrations for 7-ketositosterol in serum
from phytosterolaemic patients.
E. Ryan et al.444
Treatment of U937 cells with b-sitosterol oxides in the presence
of a /g-tocopherol or b-carotene
U937 cells were adjusted to a density of 2 £ 105 cells/ml sup-
plemented with reduced serum media, 2·5 % (v/v) FCS. Cells
were treated with 10mM of a-tocopherol or g-tocopherol or
2mM-b-carotene for 1 h at 378C and 5 % (v/v) CO2. Subsequently,
cells were treated with 30mM-7b-hydroxycholesterol or 120mM-
7b-hydroxysitosterol or 7-ketositosterol. All compounds were dis-
solved (with the exception of b-carotene) in ethanol and the final
concentration in the cultures did not exceed 0·4 % (v/v). b-Caro-
tene was dissolved in hexane and the final concentration in the
cultures did not exceed 0·4 % (v/v). Equivalent quantities of etha-
nol /hexane were added to the control cells. To determine if the
tocopherols or b-carotene had any effect on toxicity, the cells
were also incubated with these compounds alone. Samples were
incubated for 24 h at 378C and 5 % (v/v) CO2.
Cell viability
The viability of the U937 cells was assessed after 24 h by the flur-
ochrome-mediated viability assay as previously described by
Strauss (1991). Briefly, cells were mixed 1:1 (v/v) with a solution
of fluorescein diacetate and ethidium bromide, then incubated at
378C for 5 min before being layered onto a microscope slide.
Under these conditions, viable cells fluoresce green, whereas
non-viable cells fluoresce red. Samples were examined at £ 200
magnification on a Nikon fluorescence microscope (The micron
optical Co. Ltd., Enriscorthy, Co. Wexford, Ireland) using blue
light (450–490 nm). Two hundred cells were scored from each
slide and cell viability was expressed as the percentage of viable
(green) cells.
The viability of the CaCo-2 and HepG2 cells was assessed after
24 h by the Neutral Red uptake assay as described by Borenfreund
& Puerner (1984). The Neutral Red uptake assay was chosen for
the CaCo-2 and HepG2 cells as both are adherent cell lines and
this is the most suitable viability assay for adherent cells.
Whilst the fluorescein diacetate /ethidium bromide assay can be
employed as a viability assay for the CaCo-2 and HepG2 cells,
it would have involved scraping the cells and we felt this step
might result in over- or underestimating the ratio of viable to
non-viable cells. Following treatments, medium was removed
from the cells. Neutral Red dye (50mg/ml complete medium)
was added to each well of the six-well plate and incubated for
2 h at 378C and 5 % (v/v) CO2 to allow for uptake of the dye
into the lysosomes of viable uninjured cells. The medium was
removed and cells were washed with Krebs buffer. The cells
were subsequently treated with 2 ml of 1 % glacial acetic acid/
50 % ethanol to burst cells open and release the dye. After agita-
tion for a few minutes on a plate shaker, the samples were trans-
ferred to microcuvettes and absorbance was determined
spectrophotometrically (540 nm).
Morphological analysis of cell nuclei
Nuclear morphology of control and oxysterol-treated cells was
assessed by fluorescence microscopy after staining with Hoechst
33 342. Approximately 4 £ 105 cells were centrifuged at 200 g
for 10 min to form a pellet. Hoechst 33 342 stain (200ml, 5mg/
ml) was added and the samples were incubated at 378C and 5 %
(v/v) CO2 for 1 h. Stained samples were placed on a microscope
slide and examined under UV light (Nikon Labophot fluorescence
microscope, £ 400 magnification; The Micron Optical Co. Ltd.).
A total of 300 cells per sample were analysed and the percentage
of fragmented and condensed nuclei was calculated. Apoptotic
cells were characterised by nuclear condensation of chromatin
and/or nuclear fragmentation (Dubrez et al. 1996).
DNA fragmentation assay
Detection of small DNA fragments was conducted as described in
O’Callaghan et al. (1999). Briefly, 2 £ 106 cells were harvested
and the pellets were lysed, RNAse A (0·25 mg/ml) was added
and the samples incubated at 508C for 1 h. Proteinase K (5 mg/
ml) was added and the samples were incubated at 508C for a
further 1 h before being loaded into the wells of a 1·5 % (w/v)
agarose gel. A 100–1500 bp DNA standard (Promega; Medical
Supply Co. Ltd, Dublin, Ireland) was used to assess DNA frag-
mentation. Electrophoresis was carried out in agarose gels
prepared in tri(hydroxymethyl)aminomethane–borate–EDTA
buffer at 0·3 V/mm. DNA was visualised under UV light on a
transilluminator (312 nm) after ethidium bromide staining and
photographed using a digital camera (Kodak; Anacherm Ltd,
Dublin, Ireland).
Determination of cellular glutathione levels
The cellular level of glutathione was measured according to the
method of Hissin & Hilf (1976). Briefly 2 £ 105 cells were centri-
fuged at 100 000 g for 25 min. Supernatant (100ml) was diluted in
1·8 ml phosphate–EDTA buffer (0·1 mol Na2PO3/l, 0·005 mol
EDTA/l, pH 8) and mixed with 100ml o-phthaldaldehyde (1mg/
ml). Samples were incubated at 258C for 15 min and the fluor-
escence was detected at 420 nm following activation at 350 nm.
The glutathione concentration of the samples was determined
from a standard curve. Results were adjusted for protein content
(Smith et al. 1985) and expressed as a percentage of the control.
Statistical analysis
All data points are the mean values of at least three independent
experiments. Data were analysed by ANOVA followed by Dun-
nett’s test. The software employed for statistical analysis was
Prism (Hearne Scientific Software, Dublin, Ireland).
Results
Effect of b-sitosterol oxides on cell viability
Viability was assessed in U937 cells by the fluorescein diacetate /
ethidium bromide method following exposure to b-sitosterol
oxides for 24 h. Viability in the control samples was above
90 % for all experiments. The phytosterol oxides caused no obser-
vable change in cell viability at the lower concentration of 30mM
(Table 1). In contrast, 30mM-b-epoxycholesterol, 7b-hydroxy-
cholesterol, 7-ketocholesterol and triolcholesterol caused a signifi-
cant reduction (P,0·001) in viable cells to 73, 77, 67 and 13 %,
respectively. Exposure to 60mM of 7b-hydroxysitosterol resulted
in a significant decrease (P,0·001) in cell viability to 83 %. All
other phytosterol oxides had no significant effect on cell viability
at this concentration. At 120mM, both 7b-hydroxysitosterol and
7-ketositosterol significantly reduced (P,0·001) cell viability to
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65 %. Exposure to 120mM-b-epoxysitosterol or 120mM-triolsitos-
terol caused a significant decrease (P,0·05) in viable cells to 91
and 60 %, respectively. The a-epoxysitosterol was not toxic to the
U937 cells at any of the concentrations tested.
Viability in the CaCo-2 cells was assessed by the Neutral Red
uptake assay following exposure to the oxides for 24 h. Viability
in the control samples was set at 100 %. The phytosterol oxides
caused no observable change in cell viability at the lower concen-
tration of 30mM (Table 1). In contrast, 30mM-b-epoxycholesterol,
7b-hydroxycholesterol and 7-ketocholesterol caused a significant
reduction (P,0·05) in viable cells to 64, 89 and 83 %, respect-
ively. Triolcholesterol, at 30mM, caused a considerable reduction
(P,0·001) in cell viability to 3 %. Exposure to 60mM 7b-hydro-
xysitosterol resulted in a significant decrease (P,0·05) in cell
viability to 62 %, whilst 60mM-7-ketositsoterol significantly
reduced (P,0·001) cell viability to 64 %. All other phytosterol
oxides had no significant effect on cell viability at this concen-
tration. At 120mM, 7b-hydroxysitosterol, 7-ketositosterol and
triolsitosterol significantly reduced (P,0·001) cell viability to
41, 23 and 55 %, respectively. The a-epoxysitosterol–b-epoxysi-
tosterol mixture (6:1), at 120mM, also caused a significant
decrease (P,0·05) in viable cells to 77 %. At all concentrations
tested, b-epoxysitosterol and a-epoxysitosterol were not toxic to
the CaCo-2 cells.
Viability in the HepG2 cells was also assessed by the Neutral
Red uptake assay following exposure to the oxides for 24 h. Via-
bility in the control samples was set at 100 %. The phytosterol
oxides caused no observable change in cell viability at the
lower concentration of 30mM. In contrast, 30mM-b-epoxycholes-
terol caused a significant reduction (P,0·05) in viable cells to
58 % whilst triolcholesterol, at 30mM, caused a considerable
reduction (P,0·001) in cell viability to 11 %. Exposure to
60mM-7b-hydroxsitosterol or 60mM-7-ketositosterol resulted in
a significant decrease (P,0·001) in cell viability to 13 and
27 %, respectively. All other phytosterol oxides had no significant
effect on cell viability at this concentration. At 120mM, 7b-hydro-
xysitosterol and 7-ketositosterol significantly reduced (P,0·001)
cell viability to 5 and 7 %. Triolsitosterol and a-epoxysitosterol–
b-epoxysitosterol, at 120mM, also caused a significant decrease
(P,0·001) in viable cells to 66 and 73 %, respectively. As with
the CaCo-2 cells, b-epoxysitosterol and a-epoxysitosterol were
not toxic to the HepG2 cells.
Effect of b-sitosterol oxides on induction of apoptosis
Condensed and fragmented nuclei were determined by morpho-
logical examination following staining with Hoechst 33 342.
Nuclei, which were condensed or fragmented, were identified as
apoptotic cells. The apoptotic cells did not exceed 3·1 % in the
control cells (Table 2). The phytosterol oxides caused no observ-
able change in the percentage of apoptotic nuclei at the lower
concentration of 30mM. In contrast, exposure to 30mM-7b-hydro-
xycholesterol, 7-ketocholesterol, b-epoxycholesterol and triolcho-
lesterol resulted in a significant increase in apoptotic nuclei to
11 % (P,0·001), 11 % (P,0·05), 12 % (P,0·001) and 15 %
(P,0·001), respectively. Following incubation with 60mM-7b-
hydroxysitosterol, there was a significant increase (P,0·001) in
apoptotic nuclei to 12 %, whilst 60mM-7-ketositosterol signifi-
cantly increased (P,0·05) apoptotic nuclei to 17 %. All other
phytosterol oxides did not induce apoptosis at this concentration.
At 120mM, both 7b-hydroxysitosterol and 7-ketositosterol signifi-
cantly increased (P,0·001) apoptotic nuclei to 19 and 40 %,
respectively, and produced a ladder-like pattern on agarose gels
(Fig. 1). Exposure to 120mM a-epoxysitosterol–b-epoxysitos-
terol or 120mM triolsitosterol caused a significant increase
(P,0·05) in apoptotic nuclei to 21 and 10 %, respectively. For
the latter treatment groups, DNA ladders were evident on the
agarose gel (Fig. 1). Whilst b-epoxysitosterol caused a significant
increase in apoptotic nuclei to 7 %, it failed to produce a ladder-
like pattern on agarose (Fig. 1). At all concentrations tested, a-
epoxysitosterol did not induce apoptosis nor was any DNA lad-
dering evident (Fig. 1). There was no evidence of apoptosis in
either the CaCo-2 or the HepG2 cell line under any of the exper-
imental conditions in the present study (data not shown).
Ability of antioxidants to modulate phytosterol oxidation product-
induced toxicity
To assess the ability of the antioxidants a-tocopherol, g-toco-
pherol and b-carotene to modulate 7b-hydroxysitosterol- or
Table 1. Percentage of viable cells following exposure for 24 h to 30, 60 or
120mM a-epoxysitosterol (a-epox), b-epoxysitosterol (b-epox), a-epoxysitos-
terol–b-epoxysitosterol (6:1) mixture (a/b-epox), 7b-hydroxysitosterol (7b-
OH), 7-ketositosterol (7-keto) or triolsitosterol (triol). Cells were also treated
with 30mM of the corresponding cholesterol oxides (chol). All compounds
were dissolved in ethanol and equivalent quantities of ethanol (EtOH) were
added to control cells. Viability of the U937 cells was assessed by the fluor-
escein diacetate/ethidium bromide assay; viability of the CaCo-2 and HepG2
cells was assessed via the Neutral Red uptake assay
(Values are means with their standard errors of at least three independent
experiments)
% Cell viability
U937 cells CaCo-2 cells HepG2 cells
Compound Mean SE Mean SE Mean SE
Control (EtOH) 98·2 0·3 100·0 0·0 100·0 0·0
30mM-a-epox 94·0 0·9 102·6 1·2 110·6 3·9
60mM-a-epox 94·3 1·2 101·1 2·2 107·4 4·6
120mM-a-epox 95·4 1·1 101·1 4·4 107·3 4·5
30mM-a-epox chol 89·0 4·5 98·9 3·6 98·2 2·2
Control (EtOH) 97·6 0·7 100·0 0·0 100·0 0·0
30mM-b-epox 97·0 0·9 111·7 3·5 100·2 2·6
60mM-b-epox 94·3 1·3 110·2 4·7 101·5 4·8
120mM-b-epox 91·0* 0·7 109·0 0·6 99·2 1·8
30mM-b-epox chol 72·8** 1·4 63·9* 7·0 57·6* 7·0
Control (EtOH) 93·8 2·0 100·0 0·0 100·0 0·0
30mM-a/b-epox 90·7 3·6 103·8 2·6 94·9 3·0
60mM-a/b-epox 96·4 0·9 96·6 3·2 89·9 2·5
120mM-a/b-epox 77·4 10·2 76·7* 5·6 73·2** 8·4
Control (EtOH) 98·2 0·3 100·0 0·0 100·0 0·0
30mM-7b-OH 93·3 1·7 91·6 11·7 76·9 13·2
60mM-7b-OH 82·7** 1·2 61·9* 9·1 13·1** 2·1
120mM-7b-OH 64·7** 6·2 40·8** 4·0 4·6** 0·7
30mM-7b-OH chol 76·7** 2·1 88·8* 0·3 87·3 3·3
Control (EtOH) 98·2 0·3 100·0 0·0 100·0 0·0
30mM-7-keto 94·7 0·7 93·0 4·7 84·7 7·7
60mM-7-keto 88·5 2·4 64·4** 7·0 26·7** 15·1
120mM-7-keto 64·7** 6·2 23·3** 4·2 7·1** 3·1
30mM-7-keto chol 67·2** 7·3 82·9* 6·1 86·5 4·5
Control (EtOH) 95·5 1·2 100·0 0·0 100·0 0·0
30mM-triol 92·5 4·1 97·1 0·9 90·3 7·7
60mM-triol 94·5 1·1 78·6 9·2 81·6 5·1
120mM-triol 59·6* 7·6 54·8** 13·6 65·5** 9·8
30mM-triol chol 12·9** 2·5 3·0** 1·7 10·6** 5·2
Mean values were significantly different from those of the control group (ANOVA followed
by Dunnett’s test): *P,0·05, **P,0·001.
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7-ketositosterol-induced toxicity, U937 cells were first treated
with the antioxidants for 1 h and subsequently treated with the
oxides for 24 h. Viability was assessed via the fluorescein diace-
tate /ethidium bromide assay whilst condensed and fragmented
nuclei were determined by staining with Hoechst 33 342. Viability
in the control samples was above 90 % for all experiments
(Table 3). Apoptotic nuclei did not exceed 4 % in the controls.
Cell treatment with tocopherols or b-carotene alone had no
effect on cell viability or apoptotic nuclei. Exposure of U937
cells to 30mM-7b-hydroxycholesterol significantly decreased
(P,0·001) viable cells to 71 % and significantly increased
(P,0·001) the condensed and fragmented nuclei to 15 %. When
7b-hydroxycholesterol and the tocopherols were co-incubated
(30mM/10mM), both a-tocopherol and g-tocopherol inhibited
the decrease in viable cells and the increase in apoptotic nuclei
induced by the COP. Treatment of U937 cells with 120mM of
Fig. 1. Induction of DNA fragmentation following incubation for 24 h with
30mM 7b-hydroxycholesterol (7b-OH chol) or 120mM a-epoxysitosterol (a-
epox), b-epoxysitosterol (b-epox), a-epoxysitosterol–b-epoxysitosterol (6:1)
mixture (a/b-epox), triolsitosterol (triol), 7-ketositosterol (7-keto) or 7b-hydro-
xysitosterol (7b-OH). DNA fragmentation was assessed by agarose gel elec-
trophoresis. Lane 1, molecular weight marker; lane 2, solvent control; lane 3,
7b-OH chol; lane 4, a-epox; lane 5, b-epox; lane 6, a/b-epox; lane 7, triol;
lane 8, 7-keto; lane 9, 7b-OH.
Table 3. Effect of a-tocopherol (a-TOC), g-tocopherol (g-TOC)
and b-carotene (b-Car) on 7b-hydroxycholesterol (7b-OH chol)-,
7b-hydroxysitosterol (7b-OH)- and 7-ketositosterol (7-keto)-
induced toxicity. U937 cells were treated with a-TOC (10mM),
g-TOC (10mM) or b-Car (2mM) for 1 h. Subsequently, the cells
were treated with 7b-OH chol (30mM), 7b-OH (120mM) or 7-keto
(120mM) for 24 h. Samples were processed either for cell viability
or stained with Hoechst 33 342 and analysed by fluorescence
microscopy (see p. 445)
(Values are means with their standard errors of at least three
independent experiments)
% Viable cells
% Apoptotic
nuclei
Treatment Mean SE Mean SE
Control (ethanol) 97·4 1·3 3·0 0·1
Control (hexane) 91·4 3·2 3·9 1·2
a-TOC 98·4 0·7 2·2 0·2
b-TOC 97·5 0·4 2·9 0·2
b-Car 97·3 1·0 3·1 0·5
30mm-7b-OH chol 70·5** 2·7 15·2** 1·3
7b-OH chol/a-TOC 89·8 0·9 4·0 0·5
7b-OH chol/g-TOC 88·5 4·4 6·6 2·3
7b-OH chol/b-Car 77·9** 6·1 13·1** 1·6
120mm-7b-OH 54·9** 2·6 24·5** 2·5
7b-OH/b-TOC 60·4** 4·4 21·2** 3·1
7-OH/g-TOC 59·1** 4·5 25·0** 3·9
7b-OH/b-Car 62·4** 2·4 20·1** 1·0
120mm-7-keto 73·9** 2·6 26·1** 1·5
7-keto/a-TOC 84·8* 2·5 20·6** 2·0
7-keto/g-TOC 79·5** 0·3 24·0** 1·5
7-keto/b-Car 75·7** 2·4 22·8** 1·5
Mean values were significantly different from those of the control group
(ANOVA followed by Dunnett’s test): *P,0·05, **P,0·001.
Table 2. Percentage of condensed or fragmented nuclei in U937 cells following exposure for 24 h to 30, 60 or
120mM a-epoxysitosterol (a-epox), b-epoxysitosterol (b-epox), a-epoxysitosterol–b-epoxysitosterol (6:1) mixture
(a/b-epox), 7b-hydroxysitosterol (7b-OH), 7-ketositosterol (7-keto) or triolsitosterol (triol). Cells were also treated
with 30mM of the corresponding cholesterol oxides (chol). All compounds were dissolved in ethanol and equivalent
quantities of ethanol (EtOH) were added to control cells. The morphology of the nuclei was assessed using
Hoechst 33 342 stain (see p. 445), and the number of apoptotic nuclei expressed as a percentage of the total
number
(Values are means with their standard errors of at least three independent experiments)
% Apoptotic nuclei in U937 cells
Control
(EtOH) 30mM 60mM 120mM 30mM chol
Compound Mean SE Mean SE Mean SE Mean SE Mean SE
a-epox 1·6 0·3 3·1 0·5 2·9 1·2 2·4 0·7 3·4 1·2
b-epox 3·1 0·4 2·1 0·8 4·0 0·8 7·0* 0·6 12·2** 0·6
a/b-epox 1·6 0·3 1·8 0·4 5·6 2·2 20·9** 5·0 – –
7b-OH 1·9 0·1 5·9 2·1 12·3** 2·2 19·4** 1·9 11·3** 0·9
7-keto 1·9 0·1 3·0 0·2 17·1* 4·9 39·7** 3·8 11·1* 1·2
triol 0·6 0·4 0·8 0·4 2·1 0·7 9·5* 2·3 14·8** 2·8
Mean values were significantly different from those of the control group (ANOVA followed by Dunnett’s test): *P,0·05, **P,0·001.
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7b-hydroxysitosterol or 7-ketositosterol significantly decreased
(P,0·001) the viable cells to 55 and 74 % and significantly
increased (P,0·001) apoptotic nuclei to 25 and 26 %, respect-
ively. Neither a-tocopherol nor g-tocopherol offered protection
against the toxicity induced by either of these oxides. Further-
more, increasing the concentration of the tocopherols to 100mM
did not confer protection against the POP (data not shown).
b-Carotene (2mM) did not protect against COP- or POP-induced
toxicity.
Effect of b-sitosterol oxides on the antioxidant status of U937
cells
To determine the antioxidant status of U937 cells, the cellular
glutathione levels were measured. A significant decrease
(P,0·05) in glutathione content was evident following incubation
with 120mM 7b-hydroxysitosterol for 24 h (Table 4). At 30mM,
7b-hydroxycholesterol and triolcholesterol caused a significant
reduction in glutathione content to 67 % (P,0·001) and 57 %
(P,0·05) of control, respectively. None of the other compounds
affected the glutathione status of the cell.
Discussion
A limited number of studies have compared the biological effects
of COP and POP. Kakis et al. (1977) showed that 7-ketocholes-
terol inhibited cholesterogenesis by 20–30 %, whereas 7-ketosi-
tosterol had no effect. Oxides of cholesterol and a b-sitosterol–
campesterol mixture exhibited similar patterns of toxicity as indi-
cated by lactate dehydrogenase leakage, cell viability and mito-
chondria dehydrogenase activity in a cultured macrophage cell
line (C57BL/6; Adcox et al. 2001). In a more recent study,
Maguire et al. (2003) concluded that the cytotoxic effects of a
mixture of POP in U937 cells closely resemble those of the
COP 7b-hydroxycholesterol, although higher concentrations of
the POP mixture were required. However, it should be noted
that practically all of the toxicity studies carried out to date
have involved the use of mixtures of phytosterol oxides. To estab-
lish the hierarchy of toxicity of these oxides, it is critical to inves-
tigate the biological activity of single purified POP. Until
recently, a barrier to progress in this area was the lack of avail-
ability of pure phytosterol oxides. In the present study the cyto-
toxicity of pure b-sitosterol oxides, synthesised as outlined
(p. 444), was investigated. Results indicate that individual
oxides of b-sitosterol exhibit similar patterns of toxicity as the
corresponding COP in the three cell lines employed.
The b-sitosterol oxides 7-ketositosterol and 7b-hydroxysitos-
terol, oxidised at the C-7 position, were found to be the most
cytotoxic to the U937, CaCo-2 and HepG2 cell lines (Table 1).
Several in vitro studies have reported that 7-ketocholesterol and
7b-hydroxycholesterol are potent inducers of apoptosis in
human vascular cells, i.e. artery smooth muscle cells, endothelial
cells and monocyte-macrophages (Leonarduzzi et al. 2002) and
thus may have a putative role in the pathogenesis of atherosclero-
sis. In the present study, 7-ketositosterol and 7b-hydroxysitos-
terol, albeit at higher concentrations compared with the
corresponding COP, induced apoptosis in U937 cells (a monocy-
tic cell line) as determined by Hoechst staining and DNA ladders.
Cholestane-3b,5a,6b-triol (triolcholesterol) is reported to be
one of the most cytotoxic oxysterols towards rabbit aortic
smooth muscle cells (Peng et al. 1979), mouse L cells (Higley
& Taylor, 1984) and Chinese hamster V79 lung fibroblasts (Seva-
nian & Peterson, 1986) and its involvement in atherosclerosis has
been investigated (Jacobson et al. 1985; Matthias et al. 1987).
We report similar findings. Triolcholesterol was the most toxic
oxide towards the three cell lines under investigation. The triol
derivative of sitosterol was also found to be cytotoxic to the
U937, CaCo-2 and HepG2 cells and induced apoptosis in the
U937 cells. However, triolcholesterol was found to be more
toxic than the triolsitosterol. Meyer & Spitellier (1997) observed
an increase in phytosterol epoxides and triols in photoautotrophic
cell cultures during ageing. Using cholesterol epoxides and triol-
cholesterol as standards of known bioactivity, the same authors
studied the cytotoxicity of 5,6-epoxides of sitosterol and stigmas-
terol and derived 3,5,6-trihydroxyphytosteranes in mealworms
(Meyer et al. 1998). They reported that all compounds were
toxic, in particular, the 3b,5a,6b-trihydroxyphytosterols. How-
ever, the phytosterol derivatives were found to be less active
than the corresponding COP.
Results of the present study indicate that a-epoxysitosterol, an
isomer of b-epoxysitosterol, was not toxic to the cell lines
employed in this study. It had no effect on cell viability or induc-
tion of apoptosis, nor was any DNA laddering evident. Similarly,
Maguire et al. (2003) reported that the a-epoxide derivative of
sitosterol failed to induce apoptosis and was not cytotoxic
to U937 cells. While the a-epoxysterol was synthesised from
the parent compound b-sitosterol (60% purity) and all other com-
pounds employed in the press study were derived from b-sitos-
terol (99% purity), our findings are consistent with results
reported by O’Callaghan et al. (2001) for the corresponding
cholesterol oxide. In contrast, the present study found the a-epox-
ysitosterol–b-epoxysitosterol mixture (6:1) to be cytotoxic to the
CaCo-2 and HepG2 cells and induced apoptosis in the U937 cells
as indicated by Hoechst staining and DNA ladders. The b-epoxide
isomer of sitosterol induced cytotoxicity and apoptosis in the
U937 cells; however, the level of apoptosis was not great
enough to produce a ladder-like pattern on agarose gel (Fig. 1).
Table 4. Glutathione concentration in U937 cells,
expressed as a percentage of control, following
exposure for 24 h to 120mM a-epoxysitosterol
(a-epox), b-epoxysitosterol (b-epox), a-epoxysitos-
terol–b-epoxysitosterol (6:1) mixture (a/b-epox), 7b-
hydroxysitosterol (7b-OH), 7-ketositosterol (7-keto) or
triolsitosterol (triol). Cells were also treated with 30mM
of the corresponding cholesterol oxides (chol)
(Values are means with their standard errors of at
least three independent experiments)
Glutathione content (% of control) in
U937 cells
120mM 30mM chol
Compound Mean SE Mean SE
a-epox 101·5 3·0 94·5 2·8
b-epox 89·4 9·3 89·9 5·3
a/b –epox 143·2 8·5 – –
7b-OH 65·0* 5·3 66·8** 1·5
7-keto 74·9 2·3 90·5 2·9
Triol 94·7 6·6 57·2* 11·0
Mean values were significantly different from those of the con-
trol group (ANOVA followed by Dunnett’s test): *P,0·05,
**P,0·001.
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It has been proposed that the b-epoxide isomer of cholesterol is
metabolised to triolcholesterol twice as rapidly as the a-epoxide
isomer, which may explain the difference in toxicity between
these two isomeric forms (Peterson et al. 1988). A similar situ-
ation may pertain to the corresponding a- and b-epoxysitosterol
isomers.
Whilst 7b-hydroxysitosterol, 7-ketositosterol and triolsitosterol
were found to be cytotoxic to CaCo-2 and HepG2 cells, these
compounds failed to induce apoptosis in both cell lines. Similarly,
O’Callaghan et al. (2002) reported that 7b-hydroxycholesterol
induced apoptosis in U937 cells but not in HepG-2 cells as
indicated by morphological examination, flow cytometry and
DNA laddering techniques. Therefore, it can be concluded that
the cells died by necrosis rather than apoptosis. Lizard et al.
(1999) also observed a cell-specific effect for 7b-hydroxycholes-
terol and 7-ketocholesterol, which were shown to induce apopto-
sis in vascular endothelial and vascular smooth muscles cells but
necrosis in human fibroblasts.
It has been reported that glutathione depletion precedes and
may be one of the earliest events in oxysterol-induced apoptosis
(Lizard et al. 1998). In the present study, a reduction in cellular
glutathione was observed following incubation for 24 h with
120mM 7b-hydroxysitosterol and 30mM of the corresponding
COP (Table 4). Not all oxides that induced apoptosis in the pre-
sent study affected glutathione status, indicating that POP- or
COP-induced apoptosis may not be dependent on the generation
of an oxidative stress. Similarly, Therond et al. (2000) reported
that oxysterols may have a cytotoxic effect independent of the
glutathione status of the cell.
Vitamin E, in particular a-tocopherol, has been shown to
protect against lipid peroxidation (Buttriss & Diplock, 1988)
and may also protect against oxysterol-induced cytotoxicty in
vitro (Lizard et al. 2000; Lyons et al. 2001; Rosenblat &
Aviram, 2002). In the present study, a- and g-tocopherol inhib-
ited 7b-hydroxycholesterol-induced cytotoxicity and apoptosis
in U937 cells. Lyons et al. (2001) report that, despite a greater
incorporation of g-tocopherol into U937 cells, a-tocopherol, but
not g-tocopherol was more effective at inhibiting 7b-hydroxy-
cholesterol-induced apoptosis in the U937 cell culture model.
In the latter study, cells were exposed to treatment for 48 h
while the incubation period used in the present study was
24 h. It is possible that the protection seen by g-tocopherol in
the present study is lost after 48 h. Although g-tocopherol is
rapidly taken up by cells in culture, it also disappears more
quickly than a-tocopherol and is present at much lower levels
in plasma (Tran & Chan, 1992). Similarly, Uemura et al.
(2002) found that apoptosis induced by 7b-hydroxycholesterol
and 7-ketocholesterol in vascular endothelial cells was pre-
vented by a-tocopherol. These authors suggest that a-toco-
pherol was protective not only by scavenging reactive oxygen
species but also by inhibiting caspase activity. In contrast,
results from the present study indicate that a /g-tocopherol did
not confer protection against 7b-hydroxysitosterol- or 7-ketosi-
tosterol-induced cytotoxicity and apoptosis in U937 cells
(Table 3). It may be that different apoptotic pathways are pro-
voked by COP v. POP in spite of their structural similarity. We
have, for example, previously shown that different COP
(7b-hydroxycholesterol v. b-epoxycholesterol) provoked apopto-
sis by different signalling pathways (Ryan et al. 2004a). Trolox
(a water-soluble synthetic analogue of a-tocopherol) protected
against 7b-hydroxycholesterol-induced apoptosis but did not
protect against cell death induced by b-epoxycholesterol
(Ryan et al. 2004a). Clearly, more research is required to
further elucidate this interesting difference between COP- and
POP-induced apoptosis.
Carotenoids have been implicated as important dietary nutri-
ents having antioxidant potential and their beneficial effects in
human disease prevention have been widely reported (Tapiero
et al. 2004). It is known that certain COP, e.g. 7b-hydroxycholes-
terol, are able to induce oxidative stress in cells (Miguet-Alfonsi
et al. 2002; Ryan et al. 2004b). Therefore, we examined whether
the carotenoid b-carotene would protect against COP- and
POP-induced cellular toxicities. In contrast to the tocopherols,
b-carotene did not confer any protection against either COP- or
POP-induced cellular damage (Table 3). Studies to date suggest
that the antioxidant activity of carotenoids most likely involves
the scavenging of two reactive oxygen species, singlet molecular
oxygen and peroxyl radicals. On the other hand, oxidative stress
induced by 7b-hydroxycholesterol has been associated with
alterations in superoxide dismutase activity and glutathione con-
centration (Ryan et al. 2004b) and stimulation of superoxide
anion production (Miguet-Alfonsi et al. 2002).
In conclusion, our data represent the first direct comparison of
COP and POP with respect to cytotoxicity and effects on apopto-
sis. POP have qualitatively similar toxic effects to COP. However,
from a quantitative perspective, higher concentrations of POP are
required to elicit comparable degrees of cytotoxicity and modula-
tory effects on apoptosis. In addition, there may be slight differ-
ences in the apoptotic pathways provoked by these oxides. In light
of the increasing intakes of phytosterols due to the proliferation of
phytosterol-enriched foods, further investigation of the potential
toxicity of POP is warranted.
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